These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31102861)

  • 1. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
    Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
    Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F9 mRNA splicing aberration due to a deep Intronic structural variation in a patient with moderate hemophilia B.
    Odaira K; Kawashima F; Tamura S; Suzuki N; Tokoro M; Hayakawa Y; Suzuki A; Kanematsu T; Okamoto S; Takagi A; Katsumi A; Matsushita T; Shima M; Nogami K; Kojima T; Hayakawa F
    Thromb Res; 2022 May; 213():91-96. PubMed ID: 35313235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular Basis of FIX Deficiency in Hemophilia B.
    Shen G; Gao M; Cao Q; Li W
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single synonymous mutation in factor IX alters protein properties and underlies haemophilia B.
    Simhadri VL; Hamasaki-Katagiri N; Lin BC; Hunt R; Jha S; Tseng SC; Wu A; Bentley AA; Zichel R; Lu Q; Zhu L; Freedberg DI; Monroe DM; Sauna ZE; Peters R; Komar AA; Kimchi-Sarfaty C
    J Med Genet; 2017 May; 54(5):338-345. PubMed ID: 28007939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.
    Martorell L; Luce E; Vazquez JL; Richaud-Patin Y; Jimenez-Delgado S; Corrales I; Borras N; Casacuberta-Serra S; Weber A; Parra R; Altisent C; Follenzi A; Dubart-Kupperschmitt A; Raya A; Vidal F; Barquinero J
    J Thromb Haemost; 2017 Nov; 15(11):2188-2197. PubMed ID: 28834196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B.
    Nakamura Y; Murata M; Takagi Y; Kozuka T; Nakata Y; Hasebe R; Takagi A; Kitazawa J; Shima M; Kojima T
    Int J Hematol; 2015 Jul; 102(1):134-9. PubMed ID: 25739383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability.
    Yi S; Yang Q; Zuo Y; Li M; Luo J; Qin Z; Zhang Q; Li M; Huang L; Lu Y; Feng S; Fan X
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):121-126. PubMed ID: 31904612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 14 F9 synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression.
    Zhang H; Chen C; Wu X; Lou C; Liang Q; Wu W; Wang X; Ding Q
    Hum Mutat; 2022 Jul; 43(7):928-939. PubMed ID: 35391506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant suppressing factor 9 RNA biogenesis leading to hemophilia B.
    Krooss S; Werwitzke S; Kopp J; Rovai A; Varnholt D; Wachs AS; Goyenvalle A; Aarstma-Rus A; Ott M; Tiede A; Langemeier J; Bohne J
    PLoS Genet; 2020 Apr; 16(4):e1008690. PubMed ID: 32267853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of a novel Met394Thr variant causing hemophilia B.
    Lu L; Wang L; Shen W; Fang S; Zhao L; Hu X; Yang L; Wang G
    Mol Genet Genomic Med; 2023 May; 11(5):e2147. PubMed ID: 36795372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional exploration of three newly identified coagulation factor IX mutations in Chinese hemophilia B patients.
    Wang R; Jiang S; Wang X; Wei D; Xu Q; Wu W
    Int J Hematol; 2023 Aug; 118(2):201-209. PubMed ID: 37210691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.
    Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B.
    Gao M; Chen L; Yang J; Dong S; Cao Q; Cui Z; Dong Y; Liu H; Shen Y; Yang H; Hao Z; Zhang L; Li W; Tie JK; Shen G
    Blood Adv; 2024 Aug; 8(15):3893-3905. PubMed ID: 38820490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations.
    Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B.
    Ferrarese M; Testa MF; Balestra D; Bernardi F; Pinotti M; Branchini A
    Hum Mutat; 2018 May; 39(5):702-708. PubMed ID: 29388273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of F9 mutations in Chinese haemophilia B patients: identification of 20 novel mutations.
    Yu T; Dai J; Liu H; Ding Q; Lu Y; Wang H; Wang X; Fu Q
    Pathology; 2012 Jun; 44(4):342-7. PubMed ID: 22544209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.
    Saini S; Hamasaki-Katagiri N; Pandey GS; Yanover C; Guelcher C; Simhadri VL; Dandekar S; Guerrera MF; Kimchi-Sarfaty C; Sauna ZE
    Haemophilia; 2015 Mar; 21(2):210-218. PubMed ID: 25470321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.
    Katneni UK; Liss A; Holcomb D; Katagiri NH; Hunt R; Bar H; Ismail A; Komar AA; Kimchi-Sarfaty C
    Mol Genet Genomic Med; 2019 Aug; 7(8):e840. PubMed ID: 31257730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.